Arkema: 29% fall in annual EBITDA
The chemical group's sales contracted by 17.6% to 9.51 billion euros, including a 16.1% decline at constant exchange rates and scope of consolidation, with volumes down 10% and a price effect of -6.1%.
A dividend of 3.50 euros per share (versus 3.40 euros in 2022) will be proposed for the past year. Arkema is targeting EBITDA of between €1.5 and €1.7 billion in 2024, with growth to be focused mainly on the second half of the year.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction